We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
ProPetro Holding
PUMP
$1.37B
| $340K | ﹤0.01% |
+47,233
| New | +$429K |
|
1327
Jefferies Financial Group
JEF
$12.8B
| $336K | ﹤0.01% |
10,587
+2,626
| +33% | +$94.9K |
|
1328
Coherus Oncology
CHRS
$222M
| $336K | ﹤0.01% |
+49,089
| New | +$381K |
|
1329
Drilling Tools International
DTI
$84.3M
| $336K | ﹤0.01% |
+32,128
| New | +$333K |
|
1330
nLIGHT
LASR
$3.95B
| $336K | ﹤0.01% |
+32,980
| New | +$380K |
|
1331
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$315M
| $336K | ﹤0.01% |
12,000
| – | – |
|
1332
Associated Banc-Corp
ASB
$5.93B
| $336K | ﹤0.01% |
18,660
+7,582
| +68% | +$166K |
|
1333
United States Oil Fund
USO
$1.91B
| $332K | ﹤0.01% |
+5,000
| New | +$333K |
|
|
JBGS
1334
JBG SMITH
JBGS
$829M
| $331K | ﹤0.01% |
+21,965
| New | +$390K |
|
1335
Viridian Therapeutics
VRDN
$2.13B
| $331K | ﹤0.01% |
+13,000
| New | +$417K |
|
1336
Universal Insurance Holdings
UVE
$1.23B
| $330K | ﹤0.01% |
+18,100
| New | +$268K |
|
|
AYX
1337
DELISTED
Alteryx Inc
AYX
| $330K | ﹤0.01% |
5,604
+1,053
| +23% | +$61.4K |
|
|
AAC
1338
DELISTED
Ares Acquisition Corporation
AAC
| $329K | ﹤0.01% |
+31,896
| New | +$326K |
|
1339
DraftKings
DKNG
$11.7B
| $329K | ﹤0.01% |
17,000
-100
| -0.6% | -$1.66K |
|
|
1340
PUT
DraftKings
DKNG
$11.7B
| $329K | ﹤0.01% |
17,000
| – | – |
|
1341
iShares MSCI Brazil ETF
EWZ
$9.22B
| $329K | ﹤0.01% |
+12,000
| New | +$336K |
|
1342
Red Robin
RRGB
$150M
| $328K | ﹤0.01% |
+22,905
| New | +$232K |
|
1343
Atkore
ATKR
$3.16B
| $326K | ﹤0.01% |
+2,320
| New | +$314K |
|
1344
FIVE9
FIVN
$2.22B
| $326K | ﹤0.01% |
+4,504
| New | +$322K |
|
1345
Old Republic International
ORI
$10.6B
| $325K | ﹤0.01% |
+13,033
| New | +$328K |
|
|
LAC
1346
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $325K | ﹤0.01% |
14,954
-20,363
| -58% | -$450K |
|
|
MRNS
1347
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $325K | ﹤0.01% |
+47,108
| New | +$295K |
|
|
WIRE
1348
DELISTED
Encore Wire Corp
WIRE
| $325K | ﹤0.01% |
1,751
+293
| +20% | +$50K |
|
1349
ATI
ATI
$26.4B
| $324K | ﹤0.01% |
8,211
-17,168
| -68% | -$648K |
|
|
ATRI
1350
DELISTED
Atrion Corp
ATRI
| $323K | ﹤0.01% |
+515
| New | +$329K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.